Detalhe da pesquisa
1.
Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B+ vesicle pathway in liver cancer.
Proc Natl Acad Sci U S A
; 119(36): e2202730119, 2022 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36044553
2.
Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma.
Biomarkers
; 29(2): 55-67, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38361436
3.
Kinetics of the hepatitis B core-related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide.
Hepatol Res
; 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38685853
4.
Osteosarcopenia predicts poor survival in patients with cirrhosis: a retrospective study.
BMC Gastroenterol
; 23(1): 196, 2023 Jun 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37277731
5.
Poor tolerability of lenvatinib in elderly patients ≥80 years old with hepatocellular carcinoma: A multicenter observational study.
J Oncol Pharm Pract
; 29(3): 626-636, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35112972
6.
Extended-Synaptotagmin 1 Enhances Liver Cancer Progression Mediated by the Unconventional Secretion of Cytosolic Proteins.
Molecules
; 28(10)2023 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37241771
7.
Extracellular PKCδ signals to epidermal growth factor receptor for tumor proliferation in liver cancer cells.
Cancer Sci
; 113(7): 2378-2385, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35490382
8.
Misunderstanding of hepatitis C virus (HCV) infection status by non-specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy.
J Infect Chemother
; 28(9): 1231-1234, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35534339
9.
IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate.
J Gastroenterol Hepatol
; 35(4): 663-672, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31677185
10.
Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan.
J Viral Hepat
; 26(11): 1266-1275, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31278795
11.
CD4+ T cells from patients with primary biliary cholangitis show T cell activation and differentially expressed T-cell receptor repertoires.
Hepatol Res
; 49(6): 653-662, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30690835
12.
Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis.
BMC Musculoskelet Disord
; 20(1): 615, 2019 Dec 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31878909
13.
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein.
Hepatol Res
; 48(6): 424-432, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29274190
14.
An Appraisal of Current Guidelines for Managing Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasm.
JOP
; 19(4): 178-182, 2018 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-30636939
15.
Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers.
Hepatology
; 64(2): 645-51, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26849406
16.
Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder.
J Hepatol
; 60(6): 1194-202, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24530598
17.
Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers.
Hepatology
; 57(4): 1469-83, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23175232
18.
Concise review: clinical programs of stem cell therapies for liver and pancreas.
Stem Cells
; 31(10): 2047-60, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23873634
19.
Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis.
Stem Cells
; 31(9): 1966-79, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23847135
20.
A novel combined C-reactive protein-albumin ratio and modified albumin-bilirubin score can predict long-term outcomes in patients with hepatocellular carcinoma after hepatic resection.
Ann Gastroenterol Surg
; 8(1): 143-150, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38250682